Warren, R., A. Blauvelt, J. Bagel, K. Papp, P. Yamauchi, A. Armstrong, R. Langley, V. Vanvoorden, D. De Cuyper, L. Peterson, N. Cross, and K. Reich. “Bimekizumab Efficacy and Safety Versus Adalimumab in Patients With Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE)”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s15, doi:10.25251/skin.5.supp.15.